Table 1.
Baseline characteristics of the untreated and treated LNB patients and of the borrelia antibody negative patients
| |
|
|
|
Antibodies |
|
|
|
|
|
|
Presenting symptom |
|||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | No | Age, years (Median, range) | Sex (F/M) | B31a (pos/neg) | C6b (pos/neg) | IT-indexc (pos/neg/ND) | Cells/μld (Median, range) | OC-bandse (pos/neg) | Protein (mg/ml) (Median, range) | Duration of symptomsf (days) (Median, range) | Tick biteg (No of patients) | EMh (No of patients) | FPi | Radiculits/Radiating pain |
|
Untreated LNB |
38 |
66 (3–80) |
16/22 |
37/1 |
37/1 |
29/3/6 |
104 (0–1516) |
21/4 |
1034 (454–3148) |
30 (0–120) |
11 |
2 |
19 |
30 |
|
Treated LNB |
24 |
64 (34–79) |
8/16 |
22/2 |
18/6 |
19/4/1 |
35 (0–120) |
10/0 |
601 (267–1597) |
NAj |
NA |
NA |
NA |
NA |
| Non-LNB | 239 | 50 (1–91) | 133/106 | 0/239 | NDk | ND | NKl | NK | NK | NK | NK | NK | NK | NK |
aCSF antibodies to B. burgdorferi s.s B31 whole cell antigen.
bCSF antibodies to C6-peptide.
cIntrathecal antibody production index.
dCells/μl, mononuclear cell count.
eOC-bands, oligoclonal bands in CSF.
fDuration of symptoms before first CSF sampling.
gObserved tick bite.
hObserved erythema migrans.
IFP, facial nerve paralysis.
jNA: not applicable.
kND: not done.
lNK: not known.